Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Cash (2022 - 2025)

CervoMed (CRVO) has disclosed Change in Cash for 9 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 195.71% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$764027.0 through Dec 2025, down 163.32% year-over-year, with the annual reading at -$764027.0 for FY2025, 163.32% down from the prior year.
  • Change in Cash hit -$1.2 million in Q4 2025 for CervoMed, down from $1.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $29.5 million in Q3 2022 to a low of -$27.4 million in Q1 2022.
  • Historically, Change in Cash has averaged $98070.7 across 4 years, with a median of -$1.3 million in 2024.
  • Biggest five-year swings in Change in Cash: tumbled 280.03% in 2023 and later surged 285.54% in 2024.
  • Year by year, Change in Cash stood at -$692530.0 in 2022, then crashed by 280.03% to -$2.6 million in 2023, then surged by 147.72% to $1.3 million in 2024, then plummeted by 195.71% to -$1.2 million in 2025.
  • Business Quant data shows Change in Cash for CRVO at -$1.2 million in Q4 2025, $1.1 million in Q3 2025, and -$2.2 million in Q2 2025.